Cargando…
Rituximab for the Treatment of Anti-glomerular Basement Membrane Disease with Isolated Diffuse Alveolar Hemorrhage
Anti-glomerular basement membrane (GBM) disease with isolated diffuse alveolar hemorrhage (DAH) is rare. We herein report a 91-year-old man admitted with hypoxia and diagnosed with anti-GBM disease with DAH based on positive bronchoalveolar lavage and serum antibody test results. There was no renal...
Autores principales: | Kanaoka, Kensuke, Ihara, Shoichi, Nakatani, Takeshi, Minami, Seigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372275/ https://www.ncbi.nlm.nih.gov/pubmed/36261370 http://dx.doi.org/10.2169/internalmedicine.0166-22 |
Ejemplares similares
-
High neutrophils and low lymphocytes percentages in bronchoalveolar lavage fluid are prognostic factors of higher in-hospital mortality in diffuse alveolar hemorrhage
por: Kanaoka, Kensuke, et al.
Publicado: (2021) -
Durvalumab-Induced Diffuse Alveolar Hemorrhage: An Autopsy Case Report
por: Kanaoka, Kensuke, et al.
Publicado: (2020) -
Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018) -
Osimertinib-Induced Unilateral Diffuse Alveolar Hemorrhage in a Patient With Pulmonary Adenocarcinoma
por: Saeki, Shiho, et al.
Publicado: (2021) -
Rituximab for the treatment of refractory anti-glomerular basement membrane disease
por: Yang, Xue-Fen, et al.
Publicado: (2022)